SLC1A5 and endometrial cancer: In 2017, Marshall et al. found that ASCT2 was up-regulated in different subtypes of endometrial cancer, and that inhibiting glutamine uptake or down-regulating ASCT2 in vitro can reduce the growth of endometrial cancer cells [17].